Skip to main content

N447 Remark Code: Paid as Generic, Documentation Missing

N447 means payment was based on a generic equivalent because required documentation was not provided. The claim billed a brand-name drug, but without the documentation the payer requires to justify the brand, it paid at the generic rate.

Quick facts

Code
N447 (RARC N447)
Status
Active In use since July 1, 2008.
Code set
Remittance Advice Remark Codes (RARC)
Group codes
  • CO (Contractual Obligation): The reduction to the generic rate is a provider adjustment when the provider was responsible for supplying the brand justification.
  • PR (Patient Responsibility): Under some pharmacy benefits, the difference between brand and generic can become the patient's responsibility, depending on plan rules.
Official description
Payment is based on a generic equivalent as required documentation was not provided.
X12 Remittance Advice Remark Codes, retrieved September 25, 2026
Last verified
against the official X12 list.

What N447 means

Many payers pay for a brand-name drug at the generic price unless there is a documented reason the brand is necessary. N447 says that reason was not documented to the payer’s satisfaction, so the claim was priced as if the generic equivalent had been used. It usually accompanies CARC 45 or CARC 169.

This is a pricing reduction, not a denial. The drug was covered; the payment basis changed.

Common causes

  • The prescriber required the brand (for example, by marking “dispense as written”), but no medical necessity documentation reached the payer.
  • The payer requires a specific brand-necessity form, and it was not on file.
  • The documentation was sent but lacked the clinical reason, such as the patient’s prior trial of the generic.
  • A generic became available, and the payer began applying generic pricing to the brand.

How to fix it

  1. Confirm the payer’s requirement for paying the brand: form, prior authorization, or clinical notes.
  2. Get the prescriber’s documentation explaining why the generic is not appropriate for this patient.
  3. Submit it as the payer directs, with a request to reprocess at the brand rate. If the payer wants a corrected claim, use resubmission code 7 and the original claim number.
  4. If the brand was not necessary, accept the generic pricing and consider dispensing the generic going forward.

How to prevent it

When a brand is prescribed where a generic exists, check the payer’s rules before dispensing. Get brand-necessity documentation or prior authorization up front, and keep it on file for refills. For workers’ compensation, check the jurisdiction’s generic substitution rules, which can be strict.

Codes that may appear with N447

  • CO-45 (Charge exceeds fee schedule/maximum allowable or contracted/legislated fee arrangement.): The charge exceeds the allowed amount, which is now based on the generic equivalent.
  • CO-169 (Alternate benefit has been provided.): An alternate benefit was provided, here the generic equivalent.
  • N449 (Payment based on a comparable drug/service/supply.): Payment based on a comparable drug, service, or supply, without the documentation element.
  • N448 (This drug/service/supply is not included in the fee schedule or contracted/legislated fee arrangement.): The drug or supply is not included in the fee schedule or contracted arrangement.
  • CO-252 (An attachment/other documentation is required to adjudicate this claim/service.): Documentation is required to adjudicate the claim.

N447 FAQ

What documentation supports paying for the brand?

Usually a prescriber statement that the brand is medically necessary, such as a documented reaction to or failure of the generic, along with any payer-specific form.

Does N447 apply to pharmacy claims only?

It most often affects drugs, whether dispensed by a pharmacy or billed on a medical claim. Workers' compensation programs frequently apply generic pricing rules.

Can I get the difference paid later?

Often, if you submit the required documentation and request reconsideration within the payer's time limits.